Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125518321 | 12551832 | 1 | I | 20160704 | 20160713 | 20160713 | EXP | US-DRREDDYS-USA/USA/16/0081268 | DR REDDYS | RANABOTHU S, DEL RIO M. EARLY DIABETIC NEPHROPATHY IN A PEDIATRIC RENAL TRANSPLANT RECIPIENT LEADING TO END STAGE RENAL DISEASE. BLOOD PURIF. 2016;41:234-8. | 14.00 | YR | F | Y | 0.00000 | 20160713 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125518321 | 12551832 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | U | U | UNKNOWN | 90509 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125518321 | 12551832 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125518321 | 12551832 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125518321 | 12551832 | Diabetic nephropathy | |
| 125518321 | 12551832 | End stage renal disease | |
| 125518321 | 12551832 | Transplant rejection | |
| 125518321 | 12551832 | Treatment noncompliance | |
| 125518321 | 12551832 | Type 1 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |